GPRC5D-Targeted CAR T-Cell Therapy Shows Promise After BCMA Treatment Failure

Source: Pharmacy Times articles

The salvage therapy led to an 80% overall response rate in patients with relapsed, refractory multiple myeloma.
Read More

You must be logged in to post a comment.